Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
16 studies found for:    Feridex
Show Display Options
Rank Status Study
1 Completed Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran
Condition: Acute Myocardial Infarction
Intervention: Drug: Ferucarbotran (Resovist)
2 Active, not recruiting Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Condition: Pancreatic Cancer
Intervention: Drug: Superparamagnetic Iron Oxide Magnetic Resonance Imaging
3 Completed Identification of Hepatic Lesions
Condition: Hepatic Neoplasms
Intervention: Procedure: Resovist (BAY86-4884, SH U 555 A)
4 Unknown  Cell Tracking Using Superparamagnetic Particles of Iron Oxide (SPIO) and Magnetic Resonance Imaging (MRI) - A Pilot Study
Condition: Healthy Volunteer
Interventions: Biological: Administration of autologous Endorem-labelled mononuclear cells intravenously;   Drug: Administration of Endorem
5 Completed Combidex USPIO - Ultra-Small Superparamagnetic Iron Oxide
Conditions: Uterine Neoplasms;   Cervix Neoplasms;   Bladder Neoplasms;   Prostatic Neoplasms
Intervention: Procedure: MRI contrast agent Combidex (ferumoxtran-10)
6 Recruiting Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.
Condition: Breast Cancer
Interventions: Device: Tc+blue dye;   Device: Tc+SPIO;   Device: SPIO alone
7 Recruiting Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Conditions: Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node;   Metastatic Medullary Thyroid Cancer;   Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Drug: Ferumoxytol;   Device: lymphotrophic superparamagnetic nanoparticles (LSN MRI).
8 Completed Tracking Inflammatory Cells Using Superparamagnetic Particles of Iron Oxide (SPIO) and Magnetic Resonance Imaging (MRI)
Condition: Healthy
Interventions: Drug: Administration of intra-dermal Endorem;   Biological: Mantoux test;   Biological: Autologous Endorem-labelled mononuclear cells;   Drug: Administration of Endorem
9 Completed Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
Conditions: Atherosclerotic Carotid Disease;   Atheroma
Intervention: Drug: atorvastatin
10 Unknown  Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: ferucarbotran (iron-based MRI contrast agent);   Procedure: Islet transplantation;   Procedure: Magnetic resonance imaging
11 Unknown  Inflammatory Cell Trafficking After Myocardial Infarction
Conditions: Myocardial Infarction;   Inflammation
Interventions: Other: Infusion of investigational product;   Other: Cardiac magnetic resonance imaging
12 Recruiting Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI
Condition: Head and Neck Cancer
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Drug: Ferumoxytol
13 Recruiting High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases
Condition: Multiple Sclerosis
Interventions: Drug: Feraheme;   Drug: Gadolinium-based contrast
14 Unknown  Mesenchymal Stem Cells for the Treatment of MS
Condition: Multiple Sclerosis
Intervention: Biological: injection of autologous stem cells
15 Completed Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection
Condition: Melanoma Stage III or IV
Intervention: Biological: Peptide-pulsed dendritic cells
16 Unknown  Cliavist in Infectious and Degenerative Diseases of the Spine
Condition: Spine Infection
Intervention: Drug: Cliavist

Indicates status has not been verified in more than two years